Latent Gene Sequencing Reveals Familial Relationships among Chinese Epstein-Barr Virus Strains and Evidence for Positive Selection of A11 Epitope Changes

Journal of Virology

Volumn 77, Issue 21, 2003, Pages 11517-11530

  Midgley, R S ^a   Bell, A I ^a   McGeoch, D J ^b   Rickinson, A B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPITOPE; HLA A ANTIGEN; HLA A11 ANTIGEN; UNCLASSIFIED DRUG;

AFRICA; ANTIGENIC VARIATION; ARTICLE; CAUCASIAN; CHINESE; CODON; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FAMILIA; GENE SEQUENCE; GENETIC CODE; GENETIC DRIFT; GENETIC SELECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE; VIRUS LATENCY; VIRUS MUTATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; CHINA; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HLA-A ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES, CYTOTOXIC; VARIATION (GENETICS); VIRUS LATENCY;

EID: 0142092423     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.21.11517-11530.2003     Document Type: Article

References (41)

1. Abdel-Hamid, M., J. J. Chen, N. Constantine, M. Massoud, and N. Raab-Traub. 1992. EBV strain variation: geographical distribution and relation to disease state. Virology 190:168-175.
2. Burrows, J. M., S. R. Burrows, L. M. Poulsen, T. B. Sculley, D. J. Moss, and R. Khanna. 1996. Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J. Virol. 70:2490-2496.
3. Burrows, S. R., and A. D. Hislop. The immune response to Epstein-Barr virus. In A. C. Tselis and H. B. Jensen (ed.), The Epstein-Barr virus, in press. Marcell Dekker, Inc., New York, N.Y.
4. Cheung, S.-T., S.-F. Leung, K.-W. Lo, K. W. Chiu, J. S. L. Tam, T. F. Fok, P. J. Johnson, J. C. K. Lee, and D. P. Huang. 1998. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int. J. Cancer 76:399-406.
5. Dambaugh, T., K. Hennessy, L. Chamnankit, and E. Kieff. 1984. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81:7632-7636.
6. de Campos-Lima, P.-O., R. Gavioli, Q. J. Zhang, L. E. Wallace, R. Dolcetti, M. Rowe, A. B. Rickinson, and M. G. Masucci. 1993. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 260:98-100.
7. de Campos-Lima, P.-O., V. Levitsky, J. Brooks, S. P. Lee, L. F. Hu, A. B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from high A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179:1297-1305.
8. Felsenstein, J. 1989. PHYLIP-phylogeny inference package (version 3.2). Cladistics 5:164-166.
9. Gavioli, R., M. G. Kurilla, P. O. de Campos-Lima, L. E. Wallace, R. Dolcetti, R. J. Murray, A. B. Rickinson, and M. G. Masucci. 1993. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572-1578.
10. Goldman, N., and Z. Yang. 1994. A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol. Biol. Evol. 11:725-736.
11. Gutierrez, M. I., A. Raj, G. Spangler, A. Sharma, A. Hussain, J.-G. Judde, S. W. Tsao, P. W. Yuen, I. Joab, I. T. Magrath, and K. Bhatia. 1997. Sequence variations in EBNA1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J. Gen. Virol. 78:1663-1670.
12. Johannsen, E., C. L. Miller, S. R. Grossman, and E. Kieff. 1996. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJK in Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70:4179-4183.
13. Khanna, R. 1998. Geographic (not immunological) constraints define long-term evolutionary dynamics of Epstein-Barr virus. EBV Rep. 5:127-131.
14. Khanna, R., R. W. Slade, L. M. Poulsen, D. J. Moss, S. R. Burrows, J. Nicholls, and J. M. Burrows. 1997. Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J. Virol. 71:8340-8346.
15. Lee, S. P., S. Morgan, J. Skinner, W. A. Thomas, S. R. Jones, J. Sutton, R. Khanna, H. C. Whittle, and A. B. Rickinson. 1995. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T-lymphocyte epitope are prevalent in a highly B35.01-positive African population. Eur. J. Immunol. 25:102-110.
16. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen 1. Nature 375:685-688.
17. Levitsky, V., Q. J. Zhang, J. Levitskaya, M. G. Kurilla, and M. G. Masucci. 1997. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes. J. Immunol. 159:5383-5390.
18. Lung, M. L., W. P. Lam, J. Sham, D. Chong, Y. S. Zong, H. Y. Guo, and M. H. Ng. 1991. Detection and prevalence of the "f" variant of Epstein-Barr virus in southern China. Virology 185:67-71.
19. McGeoch, D. J., and A. J. Davison. 1999. The molecular evolutionary history of the herpesviruses, p. 441-465. In E. Domingo, R. Webster, and J. Holland (ed.), Origins and evolution of viruses. Academic Press, London, United Kingdom.
20. McGeoch, D. J., A. Dolan, and A. C. Ralph. 2000. Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J. Virol. 74:10401-10406.
21. Midgley, R. S., A. I. Bell, Q. Y. Yao, D. Croom-Carter, A. D. Hislop, B. M. Whitney, A. T. C. Chan, P. J. Johnson, and A. B. Rickinson. 2003. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. J. Virol. 77:11507-11516.
22. Midgley, R. S., N. M. Blake, Q.-Y. Yao, D. S. G. Croom-Carter, S.-T. Cheung, S.-F. Leung, A. T. C. Chan, P. J. Johnson, D. Huang, A. B. Rickinson, and S. P. Lee. 2000. Novel intertypic recombinants of Epstein-Barr virus in the Chinese population. J. Virol. 74:1544-1548.
23. Miller, W. E., R. H. Edwards, D. M. Walling, and N. Raab-Traub. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75:2729-2740.
24. Moss, D. J., S. R. Burrows, S. L. Silins, I. Misko, and R. Khanna. 2001. The immunology of Epstein-Barr virus infection. Philos. Trans. R. Soc. Lond. B 356:475-488.
25. Nalesnik, M. A. 1998. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD). Springer Sem. Immunopathol. 20:325-342.
26. Nielsen, R., and Z. Yang. 1998. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936.
27. Pass, R. F. 2001. Cytomegalovirus, p. 2675-2705. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams and Wilkins, Philadelphia, Pa.
28. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams and Wilkins, Philadelphia, Pa.
29. Sample, J., L. Young, B. Martin, T. Chatman, E. Kieff, and A. Rickinson. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:4084-4092.
30. Sharipo, A., M. Imreh, A. Leonchiks, S. Imreh, and M. G. Masucci. 1998. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated Iκβα with the proteasome: a new mechanism for selective inhibition of proteolysis. Nat. Med. 4:939-944.
31. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463-493.
32. Steven, N. M., A. M. Leese, N. Annels, S. Lee, and A. B. Rickinson. 1996. Epitope focusing in the primary cytotoxic T-cell response to Epstein-Barr virus and its relationship to T-cell memory. J. Exp. Med. 184:1801-1813.
33. Sung, N. S., R. H. Edwards, F. Seillier-Moiseiwitsch, A. G. Perkins, Y. Zeng, and N. Raab-Traub. 1998. EBV strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int. J. Cancer 76:207-215.
34. Yang, Z. 1998. Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol. Biol. Evol. 15:568-573.
35. Yang, Z., and J. P. Bielawski. 2000. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15:496-503.
36. Yang, Z., and R. Nielsen. 1998. Synonymous and nonsynonymous rate variation in nuclear genes of mammals. J. Mol. Evol. 46:409-418.
37. Yang, Z., and R. Nielsen. 2002. Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Mol. Biol. Evol. 19:908-917.
38. Yang, Z., R. Nielsen, N. Goldman, and A. M. Pedersen. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449.
39. Yao, Q. Y., R. J. Tierney, D. Croom-Carter, G. M. Cooper, C. J. Ellis, M. Rowe, and A. B. Rickinson. 1996. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. J. Virol. 70:4895-4903.
40. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51-88.
41. Zhao, B., D. R. Marshall, and C. E. Sample. 1995. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jκ. J. Virol. 70:4228-4236.